Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Amsterdam
Clinical trial register · Netherlands

Clinical Trials in Amsterdam, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3174 matching records held by the registry are in this view. Synced 16 Nov 2026, 03:18 UTC
3174
Studies in scope
all four open statuses
1791
Recruiting now
open to new participants
602
Lead sponsors
across recruiting studies
Top sites
Amsterdam 12 Groningen 8 Rotterdam 8 Leiden 4 Nijmegen 4
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Amsterdam

12 of 3174 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
Radboud University Medical Center
Not applicable
170
Amsterdam, Leiden, Nijmegen, Rotterdam
2026-08-10
Recruiting
Contrast-enhanced Ultrasound for Sentinel Node Detection
NCT07310758Melanoma, Breast Cancer, Head & Neck Cancer
The Netherlands Cancer Institute
Phase 2/3
91
Amsterdam
2025-09-18
Recruiting
The Netherlands Cancer Institute
Phase 1/2
96
Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2024-03-08
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
2024-02-26
Active, closed
Amsterdam UMC, location VUmc
Not applicable
180
Amsterdam
2023-07-13
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Amsterdam
2023-03-30
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
180
Amsterdam
2022-11-30
Active, closed
Genentech, Inc.
Phase 1
165
Amsterdam, Groningen
2022-10-20
Active, closed
Pierre Fabre Medicament
Phase 3
815
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Zwolle
2022-05-02
Active, closed
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
NCT05068102Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, Non-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim
Phase 1
14
Amsterdam
2022-03-03
Recruiting
Vastra Gotaland Region
Phase 1/2
74
Amsterdam, Groningen, Rotterdam
2019-04-01
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/amsterdam

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,174 studies in total at the last sync on 16 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Amsterdam that also match the filters currently applied.

How many clinical trials are recruiting in Amsterdam?

7 of the 12 studies on this page are recruiting new participants as of the 16 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Amsterdam), 12 studies
PhaseStudiesRecruitingShare
Phase 34233.3%
Not applicable2116.7%
Phase 12016.7%
Phase 1/22216.7%
Phase 2118.3%
Phase 2/3118.3%

Most active sponsors

Lead sponsors with the most studies (Amsterdam)
Lead sponsorStudiesRecruiting
The Netherlands Cancer Institute22
Amsterdam UMC, location VUmc10
Boehringer Ingelheim10
Daiichi Sankyo11
ETOP IBCSG Partners Foundation11
Genentech, Inc.10
Iovance Biotherapeutics, Inc.11
Pierre Fabre Medicament10
Radboud University Medical Center11
Regeneron Pharmaceuticals10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.